CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- 4 Open-market buy President, CEO, COB bought 396 shares at $6.31 ($2,499)
- 4 Open-market buy VP of Research and Development bought 4,000 shares at $6.66 ($26,626)
- 8-K Event Bylaws or fiscal year change
- 4 Open-market buy President, CEO, COB bought 4,500 shares at an average $6.71 ($30,201)
- 4 Open-market buy VP of Research and Development bought 7,826 shares at an average $6.73 ($52,632)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Unregistered share sale · Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 424B4 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Executive or director change · Regulation FD disclosure
Page 14 of 38 · 755 filings